-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Astrazeneca Reports Favourable Safety Profile For Efzimfotase Alfa In Phase III HPP Trials

Reuters·06/28/2026 19:53:02

Please log in to view news